Menu

Recent Interviews

Dirk Graszt, CEO, Clean Logistics SE

Dirk Graszt
CEO | Clean Logistics SE
Trettaustr.32, 21107 Hamburg (DE)

info@cleanlogistics.de

+49-4171-6791300

Interview Clean Logistics: Hydrogen challenge to Daimler + Co.


Matthew Salthouse, CEO, Kainantu Resources

Matthew Salthouse
CEO | Kainantu Resources
3 Phillip Street #19-01 Royal Group Building, 048693 Singapore (SGP)

info@krl.com.sg

+65 6920 2020

Interview Kainantu Resources: "We hold the key to growth in the Asia-Pacific region".


Justin Reid, President and CEO, Troilus Gold Corp.

Justin Reid
President and CEO | Troilus Gold Corp.
36 Lombard Street, Floor 4, M5C 2X3 Toronto, Ontario (CAN)

info@troilusgold.com

+1 (647) 276-0050

Interview Troilus Gold: "We are convinced that Troilus is more than just a mine".


27. September 2021 | 10:46 CET

BioNTech, Meta Materials, Bayer: Rich with innovations

  • Technology
Photo credits: metamaterial.com

A new car manufacturer or a new networked fitness device can trigger hype on the stock market. But the opportunities are even greater when companies bring genuine innovations to market. These include new active ingredients, pharmacological processes or pioneering achievements by engineers. We present innovators of yesterday, today and tomorrow and shed light on their growth prospects.

time to read: 3 minutes by Nico Popp
ISIN: BIONTECH SE SPON. ADRS 1 | US09075V1026 , Meta Materials Inc. | US59134N1046 , BAYER AG NA O.N. | DE000BAY0017


 

Author

Nico Popp

At home in Southern Germany, the passionate stock exchange expert has been accompanying the capital markets for about twenty years. With a soft spot for smaller companies, he is constantly on the lookout for exciting investment stories.

About the author


BioNTech: Jumping on a moving train

BioNTech's stock is undoubtedly a high-flyer. In the last three months alone, the share price has risen by more than 50%. The reasons are manifold: vaccines for children and booster vaccines for adults are coming soon and will flush the Company with new funds. In addition, the mRNA process, for which BioNTech is known along with the likes of Moderna and CureVac, has enormous potential. When the process was first researched, Hungarian researcher Katalin Karikó was thinking of curing diseases such as cancer. Vaccines were not first on her mind. But today, we can see just how great the potential is. In no time at all, she successfully produced a very effective vaccine, robust against several mutations.

With this experience and the attention of funders and governments, it should be easy for BioNTech to initiate new projects successfully. While the stock is not one of the unknown innovators, BioNTech looks back on a track record and has further potential due to its versatile mRNA technology. However, anyone who gets on board now is entering a moving train.

Meta Materials: The tech revolution for almost every industry

The situation is a little different at Meta Materials. Here, the train started moving at top speed in the summer - but drove in circles. In the meantime, investors are finding exciting price levels again. Meta Materials focuses on extremely thin coatings that have optical, physical or magnetic properties that do not exist in this form in nature. Metamaterials can be used to direct light around particular objects by changing the refractive index of light into the negative. Military vehicles, for example, could be camouflaged in this way. But many other areas could also be disrupted by ultrathin coatings. Examples include nearly invisible mobile phone antennas in window panes, data glasses and the latest generation of overhead displays.

Meta Materials has made it its mission to mass-produce these materials and significantly reduce costs. The Company has been researching this for the past ten years and has filed numerous patents itself. Now it sees itself on the home stretch and invites other engineers and scientists to help Meta Materials achieve a breakthrough. Since the principle of small devices and solutions in everyday objects promises innovations in numerous industries, the stock is an attractive bet on the future. As a first mover, Meta Materials, listed on the US tech exchange Nasdaq, is likely to get a big piece of the pie if it succeeds.

Bayer: Yesterday's innovations, today's success

The case of Bayer shows how long innovations at the right time can determine the fortunes of corporations. In 1899, the Company registered Aspirin as a trademark with the Imperial Patent Office - and the rest is history. Even today, people with a cold or hangover reach for the well-known brand-name product and keep Bayer's coffers ringing. Of course, today, Bayer is much more than just Aspirin: just over 50% of the Company's sales are in the fields of pharmaceuticals and health care. The rest is accounted for by seeds and other products. However, what is certain is that it is the innovations of the past on which the Company has been able to build.

Today, Bayer is the market leader in many areas, has presented good figures in recent quarters and is not particularly expensive. Bayer may not have any breakthroughs in the pipeline, but the Rhineland Company is certainly innovative in its new seed products. On top of that, investors can look forward to a dividend yield of around 3.5%. The stock is a solid choice but not an innovator in the classic sense.


While conservative investors make a solid choice in Bayer to sleep soundly, things could be more turbulent at BioNTech. Even the Mainz-based Company, which is used to success, could miss the mark one day, just like its Tübingen-based colleagues from CureVac. In such a case, the fall height would be high. The situation is different at Meta Materials. The technology is capable of turning all industries upside down. Nevertheless, the share of Meta Materials is still comparatively in its infancy and, despite its progressing success, is significantly cheaper today than it was a few months ago.


Author

Nico Popp

At home in Southern Germany, the passionate stock exchange expert has been accompanying the capital markets for about twenty years. With a soft spot for smaller companies, he is constantly on the lookout for exciting investment stories.

About the author



Conflict of interest & risk note

In accordance with §34b WpHG we would like to point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH may hold long or short positions in the aforementioned companies and that there may therefore be a conflict of interest. Apaton Finance GmbH may have a paid contractual relationship with the company, which is reported on in the context of the Apaton Finance GmbH Internet offer as well as in the social media, on partner sites or in e-mail messages. Further details can be found in our Conflict of Interest & Risk Disclosure.


Related comments:

20. October 2021 | 13:52 CET | by André Will-Laudien

SAP, wallstreet:online, Baidu - This is where the action is!

  • Technology

Anyone who wants to secure a piece of the market share in today's online business must develop good digital concepts and exceptional customer service. However, many of these models have simply been transformed from the old economy to the digital world and have significant breaking points in the day-to-day operational processing. Currently, the online world is at a standstill because the transfer of goods has to be confirmed manually at a warehouse exit. Many companies are working on a perfect digital flow. We take a look at some of them today.

Read

20. October 2021 | 11:26 CET | by Stefan Feulner

Plug Power, BrainChip, Software AG - Crisis and no end

  • Technology

The global economy is suffering from a chip shortage. One reason for this is blown-up supply chains due to the Corona pandemic, leading to production downtime and short-time working, especially in the automotive industry. In addition, with future technologies such as the Internet of Things, autonomous driving and artificial intelligence, there is a higher demand for semiconductors in addition to more powerful processors. An end to this dilemma is far from imminent, according to industry insiders.

Read

12. October 2021 | 13:09 CET | by André Will-Laudien

Infineon, BrainChip, Palantir - Spoiled for choice!

  • Technology

The chip shortage is having an increasingly negative impact on supply chains. In Mecklenburg-Vorpommern, short-time work has now been declared at some suppliers to the automotive industry. First, the pandemic and the associated uncertainties among consumers caused less demand. Now, demand is suddenly back, but it cannot be satisfied because the supply chains from Asia are not yet functioning properly. Market observers expect these constraints to continue into next year. The chip crisis has now existed since the Evergreen disaster in the Suez Canal and seems to be with us for longer. We take a look at some tech stocks in the near vicinity.

Read